209 related articles for article (PubMed ID: 28342318)
1. Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer.
Henry CE; Emmanuel C; Lambie N; Loo C; Kan B; Kennedy CJ; de Fazio A; Hacker NF; Ford CE
Transl Oncol; 2017 Jun; 10(3):346-356. PubMed ID: 28342318
[TBL] [Abstract][Full Text] [Related]
2. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
3. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
4. Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer.
Henry CE; Llamosas E; Djordjevic A; Hacker NF; Ford CE
Oncogenesis; 2016 May; 5(5):e226. PubMed ID: 27239958
[TBL] [Abstract][Full Text] [Related]
5. Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis.
Henry C; Hacker N; Ford C
Oncotarget; 2017 Dec; 8(68):112727-112738. PubMed ID: 29348860
[TBL] [Abstract][Full Text] [Related]
6. Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial.
Parker BA; Shatsky RA; Schwab RB; Wallace AM; ; Wolf DM; Hirst GL; Brown-Swigart L; Esserman LJ; van 't Veer LJ; Ghia EM; Yau C; Kipps TJ
Breast Cancer Res Treat; 2023 Jun; 199(2):281-291. PubMed ID: 37029329
[TBL] [Abstract][Full Text] [Related]
7. ROR1 and ROR2 expression in pancreatic cancer.
Liu D; Sharbeen G; Phillips P; ; Ford CE
BMC Cancer; 2021 Nov; 21(1):1199. PubMed ID: 34763666
[TBL] [Abstract][Full Text] [Related]
8. ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
Liu D; Gunther K; Enriquez LA; Daniels B; O'Mara TA; Tang K; Spurdle AB; Ford CE
Sci Rep; 2020 Aug; 10(1):13906. PubMed ID: 32807831
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomics on ROR1 and ROR2 orthologs.
Katoh M; Katoh M
Oncol Rep; 2005 Nov; 14(5):1381-4. PubMed ID: 16211313
[TBL] [Abstract][Full Text] [Related]
10. ROR1 and ROR2-novel targets for neuroblastoma.
Dave H; Butcher D; Anver M; Bollard CM
Pediatr Hematol Oncol; 2019 Sep; 36(6):352-364. PubMed ID: 31441359
[No Abstract] [Full Text] [Related]
11. Critical role of the Ror-family of receptor tyrosine kinases in invasion and proliferation of malignant pleural mesothelioma cells.
Saji T; Nishita M; Ogawa H; Doi T; Sakai Y; Maniwa Y; Minami Y
Genes Cells; 2018 Jul; 23(7):606-613. PubMed ID: 29845703
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Role of Receptor Tyrosine Kinase-Like Orphan Receptors in Intestinal-Type Gastric Cancer.
Nema R; Patel P; Kumar A
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2125-2134. PubMed ID: 34319035
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development.
Al-Shawi R; Ashton SV; Underwood C; Simons JP
Dev Genes Evol; 2001 Apr; 211(4):161-71. PubMed ID: 11455430
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of rat Ror1 and Ror2 genes in silico.
Katoh M; Katoh M
Int J Mol Med; 2005 Mar; 15(3):533-8. PubMed ID: 15702250
[TBL] [Abstract][Full Text] [Related]
15. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
Endo M; Doi R; Nishita M; Minami Y
J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
[TBL] [Abstract][Full Text] [Related]
16. The Ror-Family Receptors in Development, Tissue Regeneration and Age-Related Disease.
Endo M; Kamizaki K; Minami Y
Front Cell Dev Biol; 2022; 10():891763. PubMed ID: 35493090
[TBL] [Abstract][Full Text] [Related]
17. Differential subcellular localization of Ror tyrosine kinase receptors in cultured astrocytes.
Paganoni S; Anderson KL; Ferreira A
Glia; 2004 May; 46(4):456-66. PubMed ID: 15095375
[TBL] [Abstract][Full Text] [Related]
18. Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells.
Wu X; Yan T; Hao L; Zhu Y
Cancer Manag Res; 2019; 11():2803-2815. PubMed ID: 31114334
[No Abstract] [Full Text] [Related]
19. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
20. New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.
Raivola J; Dini A; Salokas K; Karvonen H; Niininen W; Piki E; Varjosalo M; Ungureanu D
Cell Mol Life Sci; 2022 May; 79(5):276. PubMed ID: 35504983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]